TriangleFOR PATIENTS · SOURCE READING
Key Points
Source: Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 27, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview
There are different types of treatment for patients with Hodgkin lymphoma.
Patients with Hodgkin lymphoma should have their treatment planned by a team of health care providers with expertise in treating lymphomas.
Treatment for Hodgkin lymphoma may cause side effects.
The following types of treatment are used:
The following types of treatment are used:
Chemotherapy
The following types of treatment are used:
Radiation therapy
The following types of treatment are used:
Targeted therapy
The following types of treatment are used:
Immunotherapy
The following types of treatment are used:
Chemotherapy with stem cell transplant
For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:
For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:
Watchful waiting
For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:
Active surveillance
For pregnant patients with Hodgkin lymphoma, treatment options also include:
For pregnant patients with Hodgkin lymphoma, treatment options also include:
Watchful waiting
For pregnant patients with Hodgkin lymphoma, treatment options also include:
Steroid therapy
New types of treatment are being tested in clinical trials.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up care may be needed.
Preserved source evidence · Independent clinical review pending · Not medical advice